Advanced Stage Head and Neck Cancer
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB06192 | Nimotuzumab | An EGFR-targeting monoclonal antibody used in the treatment of squamous cell carcinomas of the head and neck and glioblastomas. |
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|